NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease

Gut

Volumn 61, Issue 9, 2012, Pages 1323-1329

  Syn, Wing Kin ^a,b,c   Agboola, Kolade M ^a   Swiderska, Marzena ^a   Michelotti, Gregory A ^a   Liaskou, Evaggelia ^b   Pang, Herbert ^a   Xie, Guanhua ^a   Philips, George ^a   Chan, Isaac S ^a   Karaca, Gamze F ^a   Pereira, Thiago De Almeida ^a,d   Chen, Yuping ^a   Mi, Zhiyong ^e   Kuo, Paul C ^e   Choi, Steve S ^a,f   Guy, Cynthia D ^a   Abdelmalek, Manal F ^a   Diehl, Anna Mae ^a,g  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c INSTITUTE OF HEPATOLOGY   (United Kingdom)

^d FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

^f DURHAM VA MEDICAL CENTER   (United States)

^g DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; METHIONINE; OSTEOPONTIN; SONIC HEDGEHOG PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FIBROGENESIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LIVER CELL; MONONUCLEAR CELL; MYOFIBROBLAST; NATURAL KILLER CELL; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL; WILD TYPE;

ANIMALS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FIBROSIS; HEDGEHOG PROTEINS; HEPATIC STELLATE CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LYMPHOCYTE ACTIVATION; MICE; NATURAL KILLER T-CELLS; OSTEOPONTIN; SIGNAL TRANSDUCTION;

EID: 84865041500     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301857     Document Type: Article

References (38)

1. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113-21. (Pubitemid 41002048)
2. Syn WK, Teaberry V, Choi SS, et al. Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis 2009;29:200-10.
3. Gao B, Jeong WI, Tian Z. Liver: an organ with predominant innate immunity. Hepatology 2008;47:729-36. (Pubitemid 351280741)
4. Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 2009;86:513-28.
5. Asanuma T, Ono M, Kubota K, et al. Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease. Gut 2010;59:258-66.
6. Notas G, Kisseleva T, Brenner D. NK and NKT cells in liver injury and fibrosis. Clin Immunol 2009;130:16-26.
7. Geissmann F, Cameron TO, Sidobre S, et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 2005;3:e113.
8. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007;25:297-336. (Pubitemid 46697911)
9. Swain MG. Hepatic NKT cells: friend or foe? Clin Sci (Lond) 2008;114:457-66. (Pubitemid 351548754)
10. Mallevaey T, Fontaine J, Breuilh L, et al. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis. Infect Immun 2007;75:2171-80. (Pubitemid 46744303)
11. Park O, Jeong WI, Wang L, et al. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 2009;49:1683-94.
12. Jin Z, Sun R, Wei H, et al. Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells. Hepatology 2011;53:219-29.
13. Ishikawa S, Ikejima K, Yamagata H, et al. CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice. J Hepatol 2011;54:1195-204.
14. Kita H, Naidenko OV, Kronenberg M, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002;123:1031-43.
15. Harada K, Isse K, Tsuneyama K, et al. Accumulating CD57 + CD3 + natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis. Liver Int 2003;23:94-100. (Pubitemid 37265780)
16. Nuti S, Rosa D, Valiante NM, et al. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998;28:3448-55. (Pubitemid 28510755)
17. Guebre-Xabier M, Yang S, Lin HZ, et al. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology 2000;31:633-40. (Pubitemid 30118631)
18. Li Z, Soloski MJ, Diehl AM. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 2005;42:880-5. (Pubitemid 41401126)
19. Tajiri K, Shimizu Y, Tsuneyama K, et al. Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2009;21:673-80.
20. Adler M, Taylor S, Okebugwu K, et al. Intrahepatic natural killer T cell populations are increased in human hepatic steatosis. World J Gastroenterol 2011;17:1725-31.
21. Syn WK, Oo YH, Pereira TA, et al. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology 2010;51:1998-2007.
22. Li Z, Lin H, Yang S, et al. Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. Gastroenterology 2002;123:1304-10.
23. Diao H, Kon S, Iwabuchi K, et al. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 2004;21:539-50. (Pubitemid 39370509)
24. Syn WK, Choi SS, Liaskou E, et al. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology 2011;53:106-15.
25. Syn WK, Witek RP, Curbishley SM, et al. Role for hedgehog pathway in regulating growth and function of invariant NKT cells. Eur J Immunol 2009;39:1879-92.
26. Choi SS, Omenetti A, Witek RP, et al. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol 2009;297:G1093-106.
27. Omenetti A, Syn WK, Jung Y, et al. Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology 2009;50:518-27.
28. Philips GM, Chan IS, Swiderska M, et al. Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer. PLoS One 2011;6:e23943.
29. Syn WK, Jung Y, Omenetti A, et al. Hedgehog-mediated epithelial-to- mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology 2009;137:1478-88.e8.
30. Watarai H, Nakagawa R, Omori-Miyake M, et al. Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat Protoc 2008;3:70-8.
31. Croudace JE, Curbishley SM, Mura M, et al. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide. BMC Immunol 2008;9:71.
32. Mi Z, Guo H, Russell MB, et al. RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells. Mol Ther 2009;17:153-61.
33. Zhao L, Li T, Wang Y, et al. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int J Clin Pract 2008;62:1056-62. (Pubitemid 351793583)
34. Huang W, Zhu G, Huang M, et al. Plasma osteopontin concentration correlates with the severity of hepatic fibrosis and inflammation in HCV-infected subjects. Clin Chim Acta 2010;411:675-8.
35. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005;23:877-900. (Pubitemid 40563188)
36. Stewart GA, Lowrey JA, Wakelin SJ, et al. Sonic hedgehog signaling modulates activation of and cytokine production by human peripheral CD4+ T cells. J Immunol 2002;169:5451-7. (Pubitemid 35291642)
37. Lin F, Li Y, Cao J, et al. Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells. Mol Biol Rep 2011;38:5205-10.
38. Sieghart W, Wang X, Schmid K, et al. Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria. J Hepatol 2011;54:89-97.